MSD MASTIPLAN LC 1X20INJ

actating cows). Indications for use Treatment of clinical mastitis in lactating dairy cows caused by Staphylococcus aureus, coagulase negative staphylococci, Streptococcus agalactiae, Streptococcus dysgalactiae, Streptococcus uberis and Escherichia coli sensitive to cefapirin. Contraindications Do not use in cases of hypersensitivity to cephalosporins, other b‑lactam antibiotics or to any of the excipients. Special warnings for each target species None. Special precautions for use Do not use the cleaning towels on teats with open wounds. Official, national and regional antimicrobial policies should be taken into account when the product is used. Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the target bacteria. Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the cefapirin and may decrease the effectiveness of the treatment. Operator warnings Penicillins and cephalosporins may cause hypersensitivity (allergy) following injection, inhalation, ingestion or skin contact. Hypersensitivity to penicillins may lead to cross sensitivity to cephalosporin and vice versa. Allergic reactions to these substances may occasionally be serious. Do not handle this product if you know you are sensitised to penicillins or cephalosporins or if you have been advised not to work with such preparation. Handle this product with care to avoid exposure, taking all recommended precautions. If you develop symptoms following exposure, such as a skin rash, you should seek medical advice and show the Doctor this warning. Swellings of the face, lips or eyes or difficulty breathing are more serious symptoms and require urgent medical attention. Wash hands after using the cleaning towels and wear protective gloves if skin irritation due to isopropyl alcohol is known or suspected Adverse reactions In very rare cases immediate hypersensitivity reactions may occur. The frequency of adverse reactions is defined using the following convention: -very common (more than 1 in 10 animals displaying adverse reaction(s) during the course of one treatment) -common (more than 1 but less than 10 animals in 100 animals) -uncommon (more than 1 but less than 10 animals in 1,000 animals) -rare (more than 1 but less than 10 animals in 10,000 animals) -very rare (less than 1 animal in 10,000 animals, including isolated reports). Use during pregnancy or lactation The veterinary medicinal product is intended for use during lactation. Laboratory studies in mice, rats, rabbits, and hamster have not produced any evidence of a teratogenic, foetotoxic, maternotoxic effects. Because no specific studies have been performed in the target animal species, use only according to the benefit/risk assessment by the responsible veterinarian during pregnancy and in breeding animals. Interactions The concurrent use with bacteriostatic antibiotics may cause antagonistic effects. The concurrent use of parenteral aminoglycosides or other nephrotoxic drugs is not recommended.
Vat Rate: 20%